MedPath

Opioid Receptors Influence Ischemia-Reperfusion Injury

Not Applicable
Suspended
Conditions
Ischemia-Reperfusion Injury
Registration Number
NCT00184938
Lead Sponsor
Radboud University Medical Center
Brief Summary

The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning. Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size. This mechanism can be mimicked by several pharmacological substances such as adenosine and morphine.

We, the researchers at Radboud University Nijmegen Medical Centre, have recently developed a method in which we can detect ischemia-reperfusion injury in the human forearm by using Annexin A5 scintigraphy (Rongen et al). With this method we will determine whether opioid receptors are involved in ischemic preconditioning. We expect to find that morphine can mimic ischemic preconditioning and that acute ischemic preconditioning can be blocked with the opioid receptor antagonist naloxon. This study will increase our knowledge about the mechanism of ischemic preconditioning and may also provide leads to exploit this endogenous protective mechanism in a clinical setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Healthy male volunteers
Exclusion Criteria
  • Exposition to radiation due to imaging techniques in the previous five years

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Percentual difference in Annexin A5 targetting between the experimental and control arm 1 and 4 hours after intravenous injection
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath